Search research articles
Contact Us
Filters
Showing results (151-160 of 201) with videos related to
Page
of 21
Sort By:
British Journal of Haematology
|
April 27, 2017
Earlier defibrotide initiation post-diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome improves Day +100 survival following haematopoietic stem cell transplantation
Paul G Richardson, Angela R Smith, Brandon M Triplett, et al.
Parasites & Vectors
|
May 26, 2026
Mapping tick-borne hazard across gradients of urban intensity in metropolitan regions
Wen Fu, Marie V Lilly, Sung-Joo Lee, et al.
American Journal of Public Health
|
December 8, 2021
Adapting Survey Data Collection to Respond to the COVID-19 Pandemic: Experiences From a Local Health Department
Amber Levanon Seligson, Karen A Alroy, Michael Sanderson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 12, 2003
Phase I dose-escalating study of SU11654, a small molecule receptor tyrosine kinase inhibitor, in dogs with spontaneous malignancies
Cheryl A London, Alison L Hannah, Regina Zadovoskaya, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 12, 2011
HSP90 inhibition is effective in breast cancer: a phase II trial of tanespimycin (17-AAG) plus trastuzumab in patients with HER2-positive metastatic breast cancer progressing on trastuzumab
Shanu Modi, Alison Stopeck, Hannah Linden, et al.
The American Journal of Tropical Medicine and Hygiene
|
June 4, 2010
Household-based sero-epidemiologic survey after a yellow fever epidemic, Sudan, 2005
Eileen C Farnon, L Hannah Gould, Kevin S Griffith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 2007
Combination of trastuzumab and tanespimycin (17-AAG, KOS-953) is safe and active in trastuzumab-refractory HER-2 overexpressing breast cancer: a phase I dose-escalation study
Shanu Modi, Alison T Stopeck, Michael S Gordon, et al.
Epidemiology and Infection
|
May 18, 2022
Prevalence of SARS-CoV-2 antibodies during phased access to vaccination: results from a population-based survey in New York City, September 2020-March 2021
Jannae C Parrott, Ariana Maleki Annibale, Sukhminder Osahan, et al.
Foodborne Pathogens and Disease
|
December 29, 2010
Laboratory practices for the identification of Shiga toxin-producing Escherichia coli in the United States, FoodNet sites, 2007
Dina Hoefer, Sharon Hurd, Carlota Medus, et al.
Leukemia Research
|
May 26, 2004
Effects of SU5416, a small molecule tyrosine kinase receptor inhibitor, on FLT3 expression and phosphorylation in patients with refractory acute myeloid leukemia
Anne-Marie O'Farrell, Helene A Yuen, Beverly Smolich, et al.
Page
of 21
Search research articles
Search
Showing results (151-160 of 201) with videos related to
Sort By:
Page
of 21
British Journal of Haematology
|
April 27, 2017
Earlier defibrotide initiation post-diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome improves Day +100 survival following haematopoietic stem cell transplantation
Paul G Richardson, Angela R Smith, Brandon M Triplett, et al.
Parasites & Vectors
|
May 26, 2026
Mapping tick-borne hazard across gradients of urban intensity in metropolitan regions
Wen Fu, Marie V Lilly, Sung-Joo Lee, et al.
American Journal of Public Health
|
December 8, 2021
Adapting Survey Data Collection to Respond to the COVID-19 Pandemic: Experiences From a Local Health Department
Amber Levanon Seligson, Karen A Alroy, Michael Sanderson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 12, 2003
Phase I dose-escalating study of SU11654, a small molecule receptor tyrosine kinase inhibitor, in dogs with spontaneous malignancies
Cheryl A London, Alison L Hannah, Regina Zadovoskaya, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 12, 2011
HSP90 inhibition is effective in breast cancer: a phase II trial of tanespimycin (17-AAG) plus trastuzumab in patients with HER2-positive metastatic breast cancer progressing on trastuzumab
Shanu Modi, Alison Stopeck, Hannah Linden, et al.
The American Journal of Tropical Medicine and Hygiene
|
June 4, 2010
Household-based sero-epidemiologic survey after a yellow fever epidemic, Sudan, 2005
Eileen C Farnon, L Hannah Gould, Kevin S Griffith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 2007
Combination of trastuzumab and tanespimycin (17-AAG, KOS-953) is safe and active in trastuzumab-refractory HER-2 overexpressing breast cancer: a phase I dose-escalation study
Shanu Modi, Alison T Stopeck, Michael S Gordon, et al.
Epidemiology and Infection
|
May 18, 2022
Prevalence of SARS-CoV-2 antibodies during phased access to vaccination: results from a population-based survey in New York City, September 2020-March 2021
Jannae C Parrott, Ariana Maleki Annibale, Sukhminder Osahan, et al.
Foodborne Pathogens and Disease
|
December 29, 2010
Laboratory practices for the identification of Shiga toxin-producing Escherichia coli in the United States, FoodNet sites, 2007
Dina Hoefer, Sharon Hurd, Carlota Medus, et al.
Leukemia Research
|
May 26, 2004
Effects of SU5416, a small molecule tyrosine kinase receptor inhibitor, on FLT3 expression and phosphorylation in patients with refractory acute myeloid leukemia
Anne-Marie O'Farrell, Helene A Yuen, Beverly Smolich, et al.
Page
of 21